MANGOCEUTICALS, INC. Completes Asset Acquisition, Discloses Equity Sales
Ticker: MGRX · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | medium |
| Pages | 10 |
| Reading Time | 13 min |
| Key Dollar Amounts | $0.0001, $360,000, $7,500, $10,000,000, $0.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, equity-sale, corporate-action
TL;DR
MangoC's bought assets, sold stock, and changed execs on Dec 13.
AI Summary
On December 13, 2024, MANGOCEUTICALS, INC. announced the completion of its acquisition of certain assets. The filing also disclosed unregistered sales of equity securities and material modifications to the rights of security holders. Additionally, there were changes in the company's officers and directors, along with details on compensatory arrangements.
Why It Matters
This filing indicates significant corporate actions, including an acquisition and equity sales, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details an acquisition, unregistered equity sales, and changes in control/officers, which can introduce complexities and potential risks.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- December 13, 2024 (date) — Date of Earliest Event Reported
FAQ
What specific assets were acquired by MANGOCEUTICALS, INC.?
The filing indicates the completion of an acquisition or disposition of assets but does not specify the exact assets acquired.
What was the nature of the unregistered sales of equity securities?
The filing notes unregistered sales of equity securities but does not provide details on the amount, price, or type of securities sold.
What material modifications were made to the rights of security holders?
The filing mentions material modifications to the rights of security holders but does not elaborate on the specific changes.
Were there any changes in the control of MANGOCEUTICALS, INC.?
The filing lists 'Changes in Control of Registrant' as an item, suggesting potential changes, but does not provide specific details.
What were the recent changes in MANGOCEUTICALS, INC.'s directors or officers?
The filing indicates 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers,' suggesting recent personnel changes.
Filing Stats: 3,144 words · 13 min read · ~10 pages · Grade level 11.9 · Accepted 2024-12-19 17:30:45
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 Par Value Per Share MGRX The Nasdaq
- $360,000 — iv) increase Mr. Cohen's base salary to $360,000 per year and provide that any cash bonu
- $7,500 — ohen to be paid a flat fee allowance of $7,500 per month which is intended to cover th
- $10,000,000 — the right to earn a cash bonus of up to $10,000,000, during the term of the A&R Agreement,
- $0.50 — Mango & Peaches at a conversion rate of $0.50 per share, as equitably adjusted for st
- $150,000 — s, as lender, in the original amount of $150,000, in consideration for $150,000. The d
Filing Documents
- form8-k.htm (8-K) — 77KB
- ex3-1.htm (EX-3.1) — 64KB
- ex3-2.htm (EX-3.2) — 249KB
- ex10-1.htm (EX-10.1) — 177KB
- ex10-2.htm (EX-10.2) — 39KB
- ex10-3.htm (EX-10.3) — 299KB
- ex10-4.htm (EX-10.4) — 41KB
- ex99-1.htm (EX-99.1) — 18KB
- ex3-1_001.jpg (GRAPHIC) — 11KB
- ex3-1_002.jpg (GRAPHIC) — 393KB
- ex3-1_003.jpg (GRAPHIC) — 381KB
- ex3-1_004.jpg (GRAPHIC) — 402KB
- ex3-1_005.jpg (GRAPHIC) — 436KB
- ex3-1_006.jpg (GRAPHIC) — 185KB
- ex10-1_001.jpg (GRAPHIC) — 168KB
- 0001493152-24-050830.txt ( ) — 4020KB
- mgrx-20241213.xsd (EX-101.SCH) — 3KB
- mgrx-20241213_lab.xml (EX-101.LAB) — 33KB
- mgrx-20241213_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MANGOCEUTICALS, INC. Date: December 19, 2024 By: /s/ Jacob D. Cohen Jacob D. Cohen Chief Executive Officer